David Tapolczay
CIK: 0001991789
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
CDT
CONDUIT PHARMACEUTICALS INC.
DirectorOfficer
Discretionary Trading P&L
Holdings
About Tapolczay David
Tapolczay David (SEC CIK 0001991789) files insider reports with the SEC as Chief Executive Officer of CONDUIT PHARMACEUTICALS INC. (CDT).
Signal8 holds 1 ownership filing by Tapolczay David, a Form 4, filed on Nov 20, 2024. Those filings report 1 transaction, the latest on Nov 18, 2024. Signal8's Form 4 history starts in Sep 2024.
The business address on Tapolczay David's filings is in NAPLES, FL.
Recent filings by Tapolczay David
- Nov 18, 2024: Grant or award of CDT derivative securities (Form 4, code A).
Other insiders filing for CONDUIT PHARMACEUTICALS INC. (CDT)
- Regan Andrew, Chief Executive Officer
- Manoira Corp, 10% Owner
- Taylor Mark Andrew, 10% Owner
- Farley Chele Chiavacci, Director
- Bligh James, Interim CFO
- Fry Simon Jeremy, Director